Five-year follow-up of phase II trial of autologous cord blood mononuclear cells for bronchopulmonary dysplasia prevention in very preterm infants

Zhuxiao Ren, Jiangxue Han, Qi Zhang, Wei Wei, Yongsheng Li, Shumei Yang, Fang Xu, Chuan Nie

Open source

DOI
10.1093/stcltm/szag045
Published
2026-07-20
Container
Stem Cells Translational Medicine
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/stcltm/szag045,
  title = {Five-year follow-up of phase II trial of autologous cord blood mononuclear cells for bronchopulmonary dysplasia prevention in very preterm infants},
  author = {Zhuxiao Ren and Jiangxue Han and Qi Zhang and Wei Wei and Yongsheng Li and Shumei Yang and Fang Xu and Chuan Nie},
  year = {2026},
  journal = {Stem Cells Translational Medicine},
  doi = {10.1093/stcltm/szag045},
  url = {https://doi.org/10.1093/stcltm/szag045}
}

RIS

TY  - JOUR
TI  - Five-year follow-up of phase II trial of autologous cord blood mononuclear cells for bronchopulmonary dysplasia prevention in very preterm infants
AU  - Zhuxiao Ren
AU  - Jiangxue Han
AU  - Qi Zhang
AU  - Wei Wei
AU  - Yongsheng Li
AU  - Shumei Yang
AU  - Fang Xu
AU  - Chuan Nie
PY  - 2026
JO  - Stem Cells Translational Medicine
DO  - 10.1093/stcltm/szag045
UR  - https://doi.org/10.1093/stcltm/szag045
ER  - 

APA

Ren, Z., Han, J., Zhang, Q., Wei, W., Li, Y., Yang, S., Xu, F., & Nie, C. (2026). Five-year follow-up of phase II trial of autologous cord blood mononuclear cells for bronchopulmonary dysplasia prevention in very preterm infants. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szag045

Source records